# Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma

> **NCT02517918** · PHASE1 · COMPLETED · sponsor: **Institut Bergonié** · enrollment: 23 (actual)

## Conditions studied

- Solid Tumor
- Osteosarcoma

## Interventions

- **DRUG:** Sirolimus combined with CP, MT and ZA

## Key facts

- **NCT ID:** NCT02517918
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-09-05
- **Final completion:** 2021-11-16
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517918, "Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02517918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*